Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas
一项针对复发性高级别星形细胞瘤患者的 I 期剂量递增研究,评估前体胱天蛋白酶激活化合物-1 与替莫唑胺联合用药的疗效
期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdad087
Holdhoff, Matthias; Nicholas, M Kelly; Peterson, Richard A; Maraka, Stefania; Liu, Li C; Fischer, James H; Wefel, Jeffrey S; Fan, Timothy M; Vannorsdall, Tracy; Russell, Meredith; Iacoboni, Michaella; Tarasow, Theodore M; Hergenrother, Paul J; Dudek, Arkadiusz Z; Danciu, Oana C